Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | ESR1 | P03372 | 3/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.57 |
| ▸ | AR | P10275 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | HTR6 | P50406 | 1/20 | 0.57 |
| ▸ | ESRRG | P62508 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9818198 | 0.93 | SMN1; SMN2 (0.68) | CYP3A4SMN1; SMN2ARHPGDTSHR | |
| SCHEMBL79031 | 0.93 | SMN1; SMN2 (0.68) | CYP3A4SMN1; SMN2ARHPGDTSHR | |
| SCHEMBL7261016 | 0.91 | CYP3A4 (0.55) | CYP3A4SMN1; SMN2ESR1ESR2AR | |
| SCHEMBL11176645 | 0.90 | APP (0.51) | CYP3A4SMN1; SMN2ESR1ESR2AR | |
| SCHEMBL12516039 | 0.90 | APP (0.51) | CYP3A4SMN1; SMN2ESR1ESR2AR | |
| SCHEMBL15890450 | 0.87 | SMN1; SMN2 (0.62) | CYP3A4SMN1; SMN2ARHPGDTSHR | |
| 1,3-Propanediol SCHEMBL17704098 | 0.87 | SMN1; SMN2 (0.62) | CYP3A4SMN1; SMN2ARHPGDTSHR | |
| Di(Hydroxyethyl)Ether SCHEMBL9469009 | 0.87 | SMN1; SMN2 (0.62) | CYP3A4SMN1; SMN2ARHPGDTSHR | |
| SCHEMBL9818138 | 0.87 | SMN1; SMN2 (0.62) | CYP3A4SMN1; SMN2ARHPGDTSHR | |
| SCHEMBL5707301 | 0.87 | SMN1; SMN2 (0.62) | CYP3A4SMN1; SMN2ARHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1834975-B1 | Thermosetting poly(phenylene ether) | SABIC INNOVATIVE PLASTICS IP (NL) | 2011-05-11 | — | — | EP | claimed |
| US-10023698-B2 | Curable benzoxazine compositions with improved thermal stability | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-17 | — | — | US | disclosed |
| US-20170283558-A1 | CURABLE BENZOXAZINE COMPOSITIONS WITH IMPROVED THERMAL STABILITY | 3M INNOVATIVE PROPERTIES COMPANY | 2017-10-05 | — | — | US | disclosed |
| US-20170260132-A1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2017-09-14 | — | — | US | disclosed |
| EP-2521707-B1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) | 2017-06-14 | — | — | EP | disclosed |
| US-9388112-B2 | Bisphenol derivatives and their use as androgen receptor activity modulators | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2016-07-12 | — | — | US | disclosed |
| US-9388112-B2 | Bisphenol derivatives and their use as androgen receptor activity modulators | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2016-07-12 | — | — | US | disclosed |
| EP-2289968-B1 | Polyester process | XEROX CORP (US) | 2016-04-27 | — | — | EP | disclosed |
| US-9310677-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2016-03-03 | — | — | US | disclosed |
| US-20110281124-A1 | SOLUTION AND PROCESS FOR INCREASING THE SOLDERABILITY AND CORROSION RESISTANCE OF A METAL OR METAL ALLOY SURFACE | ATOTECH USA, LLC | 2011-11-17 | — | — | US | disclosed |
| WO-2011082487-A1 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS | BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) | 2011-07-14 | — | — | WO | disclosed |
| US-20110053079-A1 | POLYESTER PROCESS | XEROX CORPORATION (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2289968-A1 | Polyester process | Xerox Corporation (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-0545407-B1 | Thermal dye transfer receiving element with polyester dye image-receiving layer | EASTMAN KODAK CO (US) | 1995-10-04 | — | — | EP | disclosed |
| US-5387571-A | Polyester containing dicarboxylic acid derived units having alicyclic ring within two carbon atoms of each carboxyl group, diol derived units having aromatic ring not immediately adjacent each hydroxyl group or alicyclic ring | EASTMAN KODAK COMPANY (US) | 1995-02-07 | — | — | US | disclosed |
| US-5223335-A | Melting linear aromatic oligomer having terminal aliphatic hydroxy group, bis/acylcaprolactam/, tetraalkoxytitanium catalyst; impregnating fibrous reinforcing material, heating to form thermoplastic copolymer matrix | TEIJIN LIMITED (JP) | 1993-06-29 | — | — | US | disclosed |
| EP-0545407-A1 | Thermal dye transfer receiving element with polyester dye image-receiving layer | EASTMAN KODAK COMPANY (US) | 1993-06-09 | — | — | EP | disclosed |
| EP-0505139-A1 | Fiber-reinforced composite material and process for the production thereof | TEIJIN LIMITED (JP) | 1992-09-23 | — | — | EP | disclosed |
| US-4756973-A | Three-dimensional network structure layer forming resin containing spirooxazine compound and phenolic resin | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023698-B2 | Curable benzoxazine compositions with improved thermal stability | BRWD1, CBX7, WIZ | CYP3A4 1003/4885SMN1; SMN2 381/4885ESR1 3080/4885 |
| US-20170260132-A1 | OXIME SULFONATE DERIVATIVES | CBR3, CBR1, C1R | CYP3A4 35/4885SMN1; SMN2 3180/4885ESR1 631/4885 |
| US-20170283558-A1 | CURABLE BENZOXAZINE COMPOSITIONS WITH IMPROVED THERMAL STABILITY | BRWD1, CBX7, WIZ | CYP3A4 1003/4885SMN1; SMN2 381/4885ESR1 3080/4885 |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | CYP3A4 25/4885SMN1; SMN2 2191/4885ESR1 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.